Gastric HP infection
Conditions
Interventions
therapy group:polaprezinc quadruple therapy
Sponsors
Sichuan Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Primary C13/C14 urea expiration test HP positive; 2. Aged 18 to 65 years; 3. Gastroscopy except gastric ulcer, gastric tumor and other major gastric diseases; 4. Sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Antibiotics, bismuth were used 4 weeks before treatment or PPI was uesd 2 weeks before treatment; 2. Pregnant or lactating women; 3. Suffering from cardiovascular and other serious diseases; 4. Those who participated in other clinical trials within 3 months; 5. Unable to express their complaints correctly, such as mental illness, severe neurosis, unable to cooperate with the experimenters; 6. With a history of drug allergy; 7. Gastroscopy contraindications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HP elimination rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Release rate of symptom after treatment; | — |
Countries
China
Contacts
Public ContactYuqian Zhao
Sichuan Cancer Hospital
Outcome results
None listed